These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 22821423)
21. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437 [TBL] [Abstract][Full Text] [Related]
22. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma. Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552 [TBL] [Abstract][Full Text] [Related]
23. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis. Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944 [TBL] [Abstract][Full Text] [Related]
24. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077 [TBL] [Abstract][Full Text] [Related]
25. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496 [TBL] [Abstract][Full Text] [Related]
26. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. Ng KY; Chai S; Tong M; Guan XY; Lin CH; Ching YP; Xie D; Cheng AS; Ma S Oncotarget; 2016 Apr; 7(17):24005-17. PubMed ID: 27006468 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression. Kim SY; Kim JK; Kim HJ; Ahn JK IUBMB Life; 2005 Sep; 57(9):651-8. PubMed ID: 16203685 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017 [TBL] [Abstract][Full Text] [Related]
29. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132 [TBL] [Abstract][Full Text] [Related]
30. Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell line. Zhao X; Zhao Z; Guo J; Huang P; Zhu X; Zhou X; Yang Z; Zhao L; Xu L; Xu J; Fu L; Zhang J; Zhang X; Dong Y; Huang G; Wang Q; Li B; Song X; Yang X; Liu S; Yi S; Yu T; Yu C; Hou L; Li J; Chen W J Biomol Screen; 2013 Apr; 18(4):378-87. PubMed ID: 23042077 [TBL] [Abstract][Full Text] [Related]
31. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation. Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071 [TBL] [Abstract][Full Text] [Related]
32. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells]. Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399 [TBL] [Abstract][Full Text] [Related]
33. [Polymorphism of hepatitis B virus x gene in hepatocellular carcinoma patients and the biological effects of HBx gene with deletion varations on QSG7701 cells]. Zhu PA; Tan DM; Peng ZT; Liu F; Song L Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):7-11. PubMed ID: 18226335 [TBL] [Abstract][Full Text] [Related]
34. Activation of protooncogene c-jun by the X protein of hepatitis B virus. Twu JS; Lai MY; Chen DS; Robinson WS Virology; 1993 Jan; 192(1):346-50. PubMed ID: 8390762 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B. Wang X; Oishi N; Shimakami T; Yamashita T; Honda M; Murakami S; Kaneko S World J Gastroenterol; 2017 May; 23(18):3252-3261. PubMed ID: 28566884 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein. Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma. Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage. Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]